Ozempic ‘microdosing’ is gaining popularity — but is it effective?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
Novo Nordisk's Sponsorship Deals With UK Pharmacies Linked To Weight-Loss Drugs Raise Ethical Concerns
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
The Bulwark3h
Ozempic and Your Community
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Medscape4h
GLP-1s: The Key to Meet BMI Cutoff for Orthopedic Surgery?
Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.
West Virginia patients are left in limbo over changing insurance coverage of obesity medications
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...
dailymemphian7d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: Ozempic, Wegovy and Zepbound. “We’ve started having the patient call and ...
Ozempic vs. Wegovy: What’s the Difference?
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Just-Food1d
GLP-1 drugs reduce US grocery spending by 6%, study claims
Users of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.